We searched PubMed for articles published in English between Jan 1, 2013, and Oct 31, 2018, using the following search terms: “disorders of consciousness”, “vegetative state”, “unresponsive wakefulness syndrome” or “minimally conscious state”, and “therapy”, “treatment”, “therapeutics”, “revalidation”, or “drugs”. Of 558 papers, 45 matched our inclusion criteria: clinical trial, open label study, observational study, and case report using validated behavioural tools to evaluate therapeutic
ReviewTherapeutic interventions in patients with prolonged disorders of consciousness
Introduction
A lot of work has been done on the accurate diagnosis of patients with disorders of consciousness1, 2 to establish prognostic indicators3, 4 and to understand the neural correlates of consciousness.5 This work is crucial because misdiagnosis can lead to important medical decisions, such as withdrawal of life-sustaining care.6 Disorders of consciousness include coma (unwakefulness, reflex behaviours only), unresponsive wakefulness syndrome (previously known as vegetative state; wakefulness but reflex behaviours only), and minimally conscious state (clinical demonstration of signs of consciousness).7, 8 Once patients recover functional communication or object use, they emerge from the minimally conscious state. Additional entities have been proposed when dissociation occurs between clinical diagnosis and neuroimaging results showing atypical brain activation, including minimally conscious state* and cognitive motor dissociation (panel 1; figure 1).14, 18 Patients who have recovered from coma can remain severely disabled for several months, years, or even decades.
With regards to therapeutic options, only a few studies have investigated the treatment of patients with disorders of consciousness. Following a landmark paper on amantadine in 2012,22 this field has evolved rapidly, with new therapeutic approaches being tested and reported, but patients' clinical management remains challenging, mostly because these patients cannot communicate and are dependent on others for care. The 2018 American practice guidelines for patients with disorders of consciousness23 only recommend amantadine for patients with unresponsive wakefulness syndrome and minimally conscious state 4–16 weeks after a traumatic brain injury on the basis of one randomised controlled trial.22 Given that the guidelines were developed on the basis of strict inclusion and exclusion criteria (eg, a minimum of 20 patients included, all at least 28 days after injury), many studies failed to meet their inclusion criteria and were not reported in these recommendations. In this Review, we critically evaluate the available therapeutic options for patients with prolonged disorders of consciousness (ie, more than 28 days) that have been studied in the past 6 years. We discuss pharmacological and non-pharmacological interventions with the strongest evidence and for which robust randomised controlled trials have been published. If no randomised controlled trials were available, we present open-label studies and anecdotal case reports with careful interpretation, because they might still provide insightful results to guide future research. We also report neuroimaging and neurophysiological results associated with positive treatment responses.
Section snippets
Pharmacological treatments
Amantadine (dopamine agonist and NMDA antagonist),22, 24, 25, 26 intrathecal baclofen (GABA agonist),27 zolpidem (non-benzodiazepine GABA agonist),28, 29, 30, 31, 32 midazolam (benzodiazepine GABA agonist),33 and ziconotide (calcium channel blocker)34 have been used to improve consciousness and functional recovery in patients with disorders of consciousness.
Non-pharmacological interventions
Non-pharmacological interventions have also been attempted to improve consciousness and functional recovery in patients with disorders of consciousness. These include non-invasive brain stimulations (eg, transcranial direct current stimulation, repeated transcranial magnetic stimulation, transcutaneous auricular vagal nerve stimulation, and low intensity focused ultrasound pulse), invasive brain stimulation (ie, deep brain stimulation or vagal nerve stimulation), and sensory stimulation
Transcranial direct current stimulation
A double-blind randomised controlled trial59 tested the effect of prefrontal transcranial direct current stimulation (ie, anode over the left dorsolateral prefrontal cortex for 20 min at 2 mA) on 55 patients, both in acute and prolonged disorders of consciousness (1 week to 26 years after injury). At the group level, behavioural improvements, as measured by the Coma Recovery Scale-Revised,46 were reported for patients in a minimally conscious state, but not for those with unresponsive
Invasive brain stimulation
A 7-year well-designed prospective open-label study89 on the effects of deep brain stimulation of the thalamic reticular nuclei in patients with disorders of consciousness (>6 months after injury) reported that only five (13%) of 40 patients met the inclusion criteria (eg, EEG desynchronised activity <5% of the recorded time, somatosensory and auditory evoked potentials evoked on at least one side). Of the five eligible patients, two did not receive surgery owing to issues with the legal
Sensory stimulation programmes
Stimulation programmes include, among others, motor-based therapy, auditory-based training, music therapy, and multi-sensory training programmes.
In a single-blind randomised controlled trial,86 the effects of conventional tilt table and its combination with a stepping device were assessed in 50 patients with disorders of consciousness (1–6 months after injury). Behavioural improvements were reported in both groups at the end of the 3-week intervention period and at the 3-week follow-up. No
Conclusions and future directions
Management of patients with disorders of consciousness is challenging because of the absence of communication, the scarcity of interaction with their environment, and their severe motor disability. Adapted therapeutic approaches that do not require patients' active participation need to be developed rapidly. Present findings suggest that some patients might benefit from rehabilitative interventions,62, 86, 87 even years after the brain injury.59, 63, 65 As highlighted in the American practice
Search strategy and selection criteria
References (99)
- et al.
Clinical and neuropsychological long-term outcomes after late recovery of responsiveness: a case series
Arch Phys Med Rehabil
(2014) - et al.
Ethical, palliative, and policy considerations in disorders of consciousness
Arch Phys Med Rehabil
(2018) - et al.
Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study
Lancet
(2014) - et al.
Measures of metabolism and complexity in the brain of patients with disorders of consciousness
NeuroImage Clin
(2017) - et al.
Consciousness in the locked-in syndrome
- et al.
Intrathecal baclofen associated with improvement of consciousness disorders in spasticity patients
Neuromodulation
(2014) - et al.
Clinical response to tDCS depends on residual brain metabolism and grey matter integrity in patients with minimally conscious state
Brain Stimul
(2015) - et al.
Non-invasive ultrasonic thalamic stimulation in disorders of consciousness after severe brain injury: a first-in-man report
Brain Stimul
(2016) - et al.
Transcutaneous auricular vagus nerve stimulation in disorders of consciousness monitored by fMRI: the first case report
Brain Stimul
(2017) - et al.
Restoring consciousness with vagus nerve stimulation
Curr Biol
(2017)